Knowledge and Uptake of Human Papilloma Virus Vaccine among Female Undergraduate Students in North-Central, Nigeria: A Cross- Sectional Study

Document Type : Original Article

Authors

1 Department of Nursing Sciences, Faculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Nigeria;

2 Faculty of Nursing Sciences, College of Health Sciences, Bowen University, Iwo, Nigeria

Abstract

Background: Human Papilloma Virus (HPV) vaccine is the most effective measure against HPV infection. Therefore, the study aimed at assessing knowledge and uptake of HPV vaccine among female undergraduates in North-Central, Nigeria.
Methods: A cross-sectional research design was conducted from March-April 2023 among female undergraduate students and a convenience sampling technique was used to select 380 respondents for the study. A self-administered questionnaire was used for data collection. Data analysis was done using SPSS version 26. Chi-square test was used to test the association between sociodemographic variables, knowledge, and uptake of HPV vaccine. Prediction of uptake of HPV vaccine according to sociodemographic variables and knowledge was done using binary logistic regression test. P-value less than 0.05 was considered statistically significant.
Results: Most of the respondents were between 20 and 25 years and were sexually inactive. The results shows that most of the respondents (68.2%) had low knowledge, and only 15% had received the HPV vaccine; of them, 7.6% had completed the doses of the HPV vaccine. Age 20-25 years (β=0.865, P=0.003), 3rd year (β=0.520, P<0.001) and 4th year (β=0.005, P<0.001) of study, sexual activity (β=0.545, P<0.001), multiple sexual partners as 3-4 partners (β=2.454, P<0.001) and 5-6 partners (β=0.576, P<0.001), prior STIs history (β=0.545, P=0.035), and low knowledge level (β=0.362, P<0.001) were predictors of HPV vaccine uptake.
Conclusion: Understanding predictor factors of HPV vaccination uptake can help to design better public health interventions to improve HPV vaccine coverage among female undergraduate students in Nigeria.

Highlights

Olayinka Abolore Onasoga (Google Scholar) (PubMed)

Keywords


  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2018;68:394-424.
  2. Oluwole EO, Idowu OM, Adejimi AA, et al. Knowledge, attitude and uptake of human papillomavirus vaccination among female undergraduates in Lagos State, Nigeria. Journal of Family Medicine and Primary Care. 2019;8:3627-33.
  3. World Health Organization. Sexually transmitted infections (STIs). Geneva: World Health Organization; 2019.
  4. World Health Organization. Cervical cancer, Key facts. Geneva: World Health Organization; 2024.
  5. World Health Organization. Global Cancer Observatory: Cancer Today. Geneva: World Health Organization; 2024.
  6. World Health Organization. Human Papillomavirus and Cancer. Geneva: World Health Organization; 2023.
  7. de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. The Lancet Global Health. 2020;8:e180-90.
  8. World Health Organization. Nigeria to vaccinate 7.7 million girls against leading cause of cervical cancer. Geneva: World Health Organization; 2023.
  9. Dorji T, Nopsopon T, Tamang ST, et al. Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis. EClinical Medicine. 2021;34:100836.
  10. Bruni LB, Albero G, Serrano B, et al. ICO/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in the world. Summary Report. Spain: ICO/IARC HPV Information Centre; 2023.
  11. Patel C, Brotherton JM, Pillsbury A, et al. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveillance. 2018;23:1700737.
  12. Kasymova S, Harrison SE, Pascal C. Knowledge and awareness of human papillomavirus among college students in South Carolina. Infectious Diseases. 2019;12:1178633718825077.
  13. Oluwasola TA, Bello OO, Odukogbe AA. Awareness and attitude of female undergraduates toward human papillomavirus vaccine in Ibadan. Tropical Journal of Obstetrics and Gynaecology. 2019;36:33-8.
  14. Habel MA, Coor A, Beltran O, et al. The state of sexual health services at US colleges and universities. Journal of American College Health. 2018;66:259-68.
  15. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2021. US: Centers for Disease Control and Prevention; 2021.
  16. Ezechi OC, Okusanya BO, Aimakhu CO, et al. Society of obstetrics and gynecology of Nigeria–Clinical practice guidelines: Guidelines for the prevention of cervical cancer. Tropical Journal of Obstetrics and Gynaecology. 2019;36:161-4.
  17. Ifediora CO, Azuike EC. Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria. Tropical Medicine & International Health. 2018;23:714-23.
  18. Azuogu BN, Umeokonkwo CD, Azuogu VC, et al. Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria. Nigerian Journal of Clinical Practice. 2019;22:1286-91.
  19. Igomu T, Folorunsho-Francis A. HPV vaccine, the cervical cancer prevention most Nigerian women don’t know. Nigeria: Health wise Punch; 2020. [Cited 2 March 2025]. Available from: https://healthwise.punchng.com/hpv-vaccine-the-cervical-cancer-prevention-most-nigerian-women-dont-know/
  20. World Health Organization. Cervical Cancer. Geneva: World Health Organization; 2024.
  21. Lekoane KM, Kuupiel D, Mashamba-Thompson TP, et al. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review. BMC Cancer. 2019;19:563.
  22. Adesina KT, Saka A, Isiaka-Lawal SA, et al. Parental perception of human papillomavirus vaccination of prepubertal girls in Ilorin, Nigeria. Saudi Journal for Health Sciences. 2018;7:65-70.
  23. Lakneh EA, Mersha EA, Asresie MB, et al. Knowledge, attitude, and uptake of human papilloma virus vaccine and associated factors among female preparatory school students in Bahir Dar City, Amhara Region, Ethiopia. PLoS One. 2022;17:e0276465.
  24. Isara AR, Osayi N. Knowledge of human papillomavirus and uptake of its vaccine among female undergraduate students of Ambrose Alli University, Ekpoma, Nigeria. Journal of Community Medicine and Primary Health Care. 2021;33:64-75.
  25. Gelassa FR, Nagari SL, Jebena DE, et al. Knowledge and practice of cervical cancer screening and its associated factors among women attending maternal health services at public health institutions in Assosa Zone, Benishangul-Gumuz, Northwest Ethiopia, 2022: A cross-sectional study. BMJ Open. 2023;13:e068860.
  26. Ayissi CA, Wamai RG, Oduwo GO, et al. Awareness, acceptability and uptake of human papilloma virus vaccine among Cameroonian school-attending female adolescents. Journal of Community Health. 2012;37:1127-35.
  27. Biyazin T, Yilma A, Yetwale A, et al. Knowledge and attitude about human papillomavirus vaccine among female high school students at Jimma town, Ethiopia. Human Vaccines & Immunotherapeutics. 2022;18:2036522.
  28. Kellogg C, Shu J, Arroyo A, et al. A significant portion of college students are not aware of HPV disease and HPV vaccine recommendations. Human Vaccines & Immunotherapeutics. 2019;15:1760-6.
  29. Wong CA, Berkowitz Z, Dorell CG, et al. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer. 2011;117:5612–20.
  30. Kayı İ, Yavaş G, Uçurum BE, et al. Predictors of human papilloma virus vaccination uptake among female university students in Turkey. Infectious Diseases & Clinical Microbiology. 2020;2:138-46.
  31. John-Akinola YO, Ndikom CM, Oluwasanu MM, et al. Cervical cancer and human papillomavirus vaccine knowledge, utilisation, prevention educational interventions and policy response in Nigeria: a scoping review. Cancer Control. 2022;29:10732748221130180.
  32. Krokidi E, Rao AP, Ambrosino E, et al. The impact of health education interventions on HPV vaccination uptake, awareness, and acceptance among people under 30 years old in India: a literature review with systematic search. Frontiers in Reproductive Health. 2023;5:1151179.
  33. McBride KR, Singh S. Predictors of adults’ knowledge and awareness of HPV, HPV-associated cancers, and the HPV vaccine: implications for health education. Health Education & Behavior. 2018;45:68-76.
  34. Mullins TL, Zimet GD, Rosenthal SL, et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Archives of Pediatrics & Adolescent Medicine. 2012;166:82-8.
  35. Gaube S, Lermer E, Fischer P. The concept of risk perception in health-related behavior theory and behavior change. In: Raue M, Streicher B, Lermer E, (eds). Perceived safety, Risk Engineering. Switzerland: Springer Cham; 2019. p. 101-18.
  36. Yarıcı F, Mammadov B. An analysis of the knowledge of adults aged between 18 and 45 on HPV along with their attitudes and beliefs about HPV vaccine: the Cyprus case. BMC Women’s Health. 2023;23:70.
  37. King C, Llewellyn C, Shahmanesh M, et al. Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study. Health Technology Assessment. 2019;23:1-122.
  38. Alves FR. The relationship between health-related knowledge and attitudes and health risk behaviours among Portuguese university students. Global Health Promotion. 2024;31:36-44.
  39. Ryan G, Avdic L, Daly E, et al. Influences on HPV vaccination across levels of the social ecological model: perspectives from state level stakeholders. Human Vaccines & Immunotherapeutics. 2021;17:1006-13.
  40. Mansfield LN, Chung RJ, Silva SG, et al. Social determinants of human papillomavirus vaccine series completion among US adolescents: a mixed-methods study. SSM-Population Health. 2022;18:101082.